Literature DB >> 8800922

Mutations in the human mannose-binding protein gene: frequencies in several population groups.

R J Lipscombe1, D W Beatty, M Ganczakowski, E A Goddard, T Jenkins, Y L Lau, A B Spurdle, M Sumiya, J A Summerfield, M W Turner.   

Abstract

Mannose-binding protein (MBP; mannan-binding protein, mannan-binding lectin) is a member of the collectin family of proteins and is thought to be important in innate immunity. We have previously shown high frequencies of two distinct mutations in codon 54 and codon 57 of exon 1 of the MBP gene in non-African and African populations, respectively. These result in low levels of the protein and an opsonic deficiency but the frequencies also suggest some selective advantage for low MBP levels. A third mutation in codon 52 occurs at a much lower frequency. We have now extended our earlier studies to other populations. In the south-west Pacific (Papua New Guinea and Vanuatu) neither the codon 52 nor the codon 57 mutation was detected and the codon 54 mutation was significantly less common (gene frequencies of 0.07 and 0.01, respectively) than in other non-African populations (gene frequencies 0.11-0.16). This could be explained by relatively recent admixture. The ancestral Melanesian population probably diverged some 50,000-60,000 years ago and our data suggest that the codon 54 mutation may have occurred after that even but before the divergence of European-Asian groups (40,000 years ago). Two further sub-Saharan populations were also studied: a group of Xhosa from South Africa were similar to Gambians, with a high gene frequency for the codon 57 mutation (0.27) and no evidence of the codon 52 or 54 mutations. In contrast, San Bushmen from Namibia had low frequencies of both the codon 57 mutation (0.07) and the codon 54 mutation (0.03). Again the codon 52 mutation was not found. This pattern is unique amongst sub-Saharan populations studied to date and suggests that this population may have been subjected to different selective pressures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800922     DOI: 10.1159/000472164

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

1.  Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition.

Authors:  O Neth; D L Jack; A W Dodds; H Holzel; N J Klein; M W Turner
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 2.  Mannose-binding lectin and the balance between immune protection and complication.

Authors:  Kazue Takahashi
Journal:  Expert Rev Anti Infect Ther       Date:  2011-12       Impact factor: 5.091

Review 3.  Innate immunity to Mycobacterium tuberculosis.

Authors:  Reinout van Crevel; Tom H M Ottenhoff; Jos W M van der Meer
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

4.  TLR and MBL gene polymorphisms in severe acute pancreatitis.

Authors:  DianLiang Zhang; HongMei Zheng; YanBing Zhou; BaoJun Yu; JieShou Li
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

Review 5.  The role of mannose-binding lectin in systemic lupus erythematosus.

Authors:  Odirlei André Monticielo; Tamara Mucenic; Ricardo Machado Xavier; João Carlos Tavares Brenol; José Artur Bogo Chies
Journal:  Clin Rheumatol       Date:  2008-01-24       Impact factor: 2.980

6.  Mannan-binding lectin (MBL) polymorphism and gastric cancer risk in Japanese population.

Authors:  Fang-Yu Wang; Tomomitsu Tahara; Tomiyasu Arisawa; Tomoyuki Shibata; Hiromi Yamashita; Masakatsu Nakamura; Daisuke Yoshioka; Masaaki Okubo; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Masahiko Nakamura; Hiroshi Fujita; Mitsuo Nagasaka; Masami Iwata; Kazuya Takahama; Makoto Watanabe; Hiroshi Nakano; Ichiro Hirata
Journal:  Dig Dis Sci       Date:  2008-03-27       Impact factor: 3.199

7.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

8.  Independent effects of genetic variations in mannose-binding lectin influence the course of HIV disease: the advantage of heterozygosity for coding mutations.

Authors:  Gabriel Catano; Brian K Agan; Hemant Kulkarni; Vanessa Telles; Vincent C Marconi; Matthew J Dolan; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2008-07-01       Impact factor: 5.226

9.  Reactive arthritis and serum levels of mannose binding lectin -- lack of association.

Authors:  H Locht; M Christiansen; I Laursen
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

10.  Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis.

Authors:  Thorsten Thye; Stefan Niemann; Kerstin Walter; Susanne Homolka; Christopher D Intemann; Margaret Amanua Chinbuah; Anthony Enimil; John Gyapong; Ivy Osei; Ellis Owusu-Dabo; Sabine Rüsch-Gerdes; Rolf D Horstmann; Stefan Ehlers; Christian G Meyer
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.